Microport Scientific (853.HK) Stock Price
Microport Scientific Price
Revenue has compounded at 18.8% per year over the past 17 years to 1.03 B USD. Earnings per share have grown at 7.3% per year over the last 12 years. Microport Scientific's net margin stands at -20.8%, up from -29.5% several years earlier. Microport Scientific currently offers a dividend yield of about 5.55%. Analysts set a median price target of 2.08 USD, implying 168.7% above the current price. Of 10 analysts, 7 rate the stock a buy — an overall Buy consensus.
Microport Scientific stock price
Microport Scientific business model & stock analysis
Frequently asked questions about Microport Scientific
The business model of Microport Scientific Corp. is centered around the research, development, and sale of high-quality medical devices. With a focus on improving healthcare outcomes, the company specializes in products for cardiovascular, orthopedic, and other medical specialties. Microport Scientific Corp. operates both domestically and internationally, catering to the needs of medical professionals and patients worldwide. By leveraging advanced technologies and innovative solutions, Microport aims to provide superior medical devices and therapies that enhance patient well-being. The company's commitment to excellence and continuous improvement has made it a prominent player in the global medical device industry.
Microport Scientific Corp is primarily active in the medical device industry.
The main competitors of Microport Scientific Corp in the market include companies such as Medtronic, Abbott Laboratories, Boston Scientific Corporation, and Johnson & Johnson. These companies operate in the medical device industry and offer similar products and solutions. Microport Scientific Corp competes with them in areas such as cardiac rhythm management, orthopedics, neurovascular, and endovascular businesses. These competitors play a significant role in shaping the competitive landscape for Microport Scientific Corp and drive innovation and advancements in the industry.
Microport Scientific Corp is a renowned medical device manufacturer based in Shanghai, China. Founded in 1998, the company has grown to become a leading player in the global cardiovascular industry. Microport specializes in the development, production, and distribution of innovative medical devices, including stents, artificial joints, electrophysiology devices, and more. With a strong emphasis on research and development, Microport strives to improve patient outcomes and enhance healthcare practices worldwide. Today, Microport Scientific Corp stands as a trusted brand in the medical field, committed to advancing medical technology and delivering high-quality products to healthcare providers and patients globally.
Some significant milestones that Microport Scientific Corp has achieved include successfully developing innovative medical technologies and gaining regulatory approvals for their products. The company has achieved milestones in the field of interventional cardiology and orthopedics, providing solutions for the treatment of cardiovascular diseases and joint disorders. Microport has also established strategic collaborations and expanded its global presence through acquisitions and partnerships. These accomplishments have strengthened Microport's position in the medical device industry and allowed them to continue delivering advanced healthcare solutions to patients worldwide.
Microport Scientific Corp is primarily present in several countries and regions, including the United States, China, Europe, and Asia-Pacific. With a global reach, Microport Scientific Corp has established its presence in key markets around the world. This enables the company to effectively serve its customers and expand its business operations.
Microport Scientific Corp is committed to delivering value-driven solutions and has a robust corporate philosophy. The company prioritizes innovation, aiming to provide cutting-edge medical devices and technology that enhance patient care. Microport focuses on creating medical solutions that are safe, effective, and accessible to a wide range of patients worldwide. Their commitment to quality and excellence is demonstrated through their stringent quality control processes and continuous improvement initiatives. With a customer-centric approach, Microport aims to meet the evolving needs of healthcare professionals and improve global healthcare outcomes. As a recognized industry leader, Microport Scientific Corp continues to drive advancements and make a positive impact in the medical field.
Analysts currently set an average price target of 1.95 USD for the Microport Scientific stock (median: 2.08 USD), implying +151.2 % versus the latest price. The consensus is based on 10 analyst ratings.
10 analysts currently rate the Microport Scientific stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Microport Scientific to generate revenue of 1.29 B USD and earnings per share of 0.03 USD.
Converted at the current exchange rate, the Microport Scientific share trades at 0.69 EUR (0.77 USD).
The Microport Scientific share (853.HK) is listed on 3 stock exchanges, including: Hongkong (HKEX) (0853.HK), Frankfurt (MSK.F).
Microport Scientific Corp is a leading medical technology company based in Shanghai, China. The company focuses on the development and manufacturing of medical devices and implantable medical aids. The core business of Microport Scientific Corp currently includes three major divisions: cardiology, orthopedics, and endovascular therapy. These divisions are specifically designed to offer products and services to hospitals and clinics worldwide that help patients and support medical personnel in diagnosis and treatment. In the cardiology division, Microport Scientific Corp offers a wide range of products, including coronary stents, balloon dilators, heart valves, and electrophysiology products. These products assist in the treatment of cardiovascular diseases such as heart attack, angina, or arrhythmia. In the orthopedics field, the company focuses on the production of hip, knee, and shoulder endoprostheses, as well as trauma implants. These implants provide a solution for patients suffering from joint diseases or injuries. Additionally, Microport Scientific Corp also manufactures spinal implants that can assist in the treatment of back pain. The company's third division, endovascular therapy, focuses on the production of devices used in blood vessels. These products can be used in the treatment of aortic aneurysms and peripheral arterial diseases. In addition to these three main divisions, Microport Scientific Corp also produces products for other medical areas, such as pressure measurement and pulmonology. The business model of Microport Scientific Corp is to develop, manufacture, and distribute medical devices and implantable medical aids worldwide. The focus is on solving medical problems that are difficult or impossible for patients to solve. The company works closely with medical professionals to ensure that the products and services provided truly meet the needs of patients and medical personnel. Continuous investment in research and development is made to develop more innovative and effective medical devices. Furthermore, the company collaborates closely with hospitals and clinics to ensure that they receive the necessary products and services and that optimal patient care is provided. Overall, Microport Scientific Corp is a successful medical technology company that specializes in the development and manufacturing of medical devices and implantable medical aids. Through close collaboration with medical professionals and hospitals, the company is able to offer products and services that meet the needs of patients and also support medical personnel in diagnosis and treatment.
The expected revenue of Microport Scientific is 1.29 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Microport Scientific is 57.67 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Microport Scientific is currently 24.60. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Microport Scientific stock.
The price-to-sales ratio (P/S) of Microport Scientific is currently 1.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Microport Scientific stock.
The Eulerpool Quality Score for Microport Scientific is 3/10.
The ISIN of Microport Scientific is KYG608371046. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Microport Scientific is A1C5AB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Microport Scientific is 853.HK. The ticker symbol is used to trade Microport Scientific shares on the stock exchange.
Microport Scientific stock
Microport Scientific Peer Group
Microport Scientific Ticker
Microport Scientific FIGI
All fundamentals and in-depth analysis of Microport Scientific
Our stock analysis for Microport Scientific stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microport Scientific. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.